Replies to post #482 on Theralink Technologies Inc (THER)

[BooDog]

I wouldn't even guess. Depends on how much they are relying on this for dilution. Not pegging the oversolds at all on the daily. Not enough volume, under the radar and in sleeper status. This quarter is due to bring on some news but it needs to catch the markets attention. Back in June I thought I was lucky getting filled at .10 lol

Till then?????

[BooDog]

If I knew I wasn't one of the very few in on this puppy I would say that seeing the increase in volume and a few of the chart indicators are starting to give out a pretty good vibe.


hmmmmm....

Vitel is actively working to next commercialize Vesanoid® (tretinoin), an oral retinoid anti-cancer chemotherapy drug, during the current quarter or early in the first quarter of 2017.
https://www.sec.gov/Archives/edgar/data/1362703/000149315216015355/form10-q.htm

Keep the news alerts set.